Wolverine Trading, LLC Immunic, Inc. Call Options Transaction History

Wolverine Trading, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$1.13 - $10.8 $45,086 - $430,920	39,900 New	39,900 $56,000
Q2 2022 Aug 15, 2022	SELL	$3.13 - $12.25 $68,547 - $268,275	-21,900 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$9.54 - $14.26 $94,445 - $141,174	9,900 Added 82.5%	21,900 $253,000
Q4 2021 Feb 14, 2022	SELL	$7.34 - $10.25 $153,406 - $214,225	-20,900 Reduced 63.53%	12,000 $115,000
Q3 2021 Nov 12, 2021	BUY	$8.05 - $13.29 $66,010 - $108,978	8,200 Added 33.2%	32,900 $299,000
Q2 2021 Aug 06, 2021	BUY	$11.76 - $16.85 $290,472 - $416,195	24,700 New	24,700 $303,000

56.2M

100

350K

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $33M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.